{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T08:37:50Z","timestamp":1774687070680,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006380","name":"Veterans Health Administration Rehabilitation Research & Development Service","doi-asserted-by":"publisher","award":["I21 RX003191"],"award-info":[{"award-number":["I21 RX003191"]}],"id":[{"id":"10.13039\/100006380","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Drug Delivery Science and Technology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.jddst.2021.102672","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T05:01:30Z","timestamp":1625806890000},"page":"102672","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Effect of fabrication parameters on morphology and drug loading of polymer particles for rosiglitazone delivery"],"prefix":"10.1016","volume":"65","author":[{"given":"Madeline R.","family":"Spetz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Isely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1622-977X","authenticated-orcid":false,"given":"R. Michael","family":"Gower","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.jddst.2021.102672_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijpharm.2008.07.018","article-title":"Microencapsulation by solvent evaporation: state of the art for process engineering approaches","volume":"363","author":"Li","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.jddst.2021.102672_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","article-title":"Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles","volume":"364","author":"Wischke","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jddst.2021.102672_bib3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2018.06.023","article-title":"Unintended effects of drug carriers: big issues of small particles","volume":"130","author":"Parhiz","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.jddst.2021.102672_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF02980037","article-title":"Control of encapsulation efficiency and initial burst in polymeric microparticle systems","volume":"27","author":"Yeo","year":"2004","journal-title":"Arch Pharm. Res. (Seoul)"},{"issue":"1\u20132","key":"10.1016\/j.jddst.2021.102672_bib5","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0378-5173(88)90073-7","article-title":"Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method","volume":"43","author":"Bodmeier","year":"1988","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.jddst.2021.102672_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0168-3659(96)01332-6","article-title":"Peptide containing microspheres from low molecular weight and hydrophilic poly(d,l-lactide-co-glycolide)","volume":"41","author":"Mehta","year":"1996","journal-title":"J. Contr. Release"},{"issue":"10","key":"10.1016\/j.jddst.2021.102672_bib7","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s40263-013-0110-x","article-title":"Extended-release intramuscular naltrexone (VIVITROL\u00ae): a review of its use in the prevention of relapse to opioid dependence in detoxified patients","volume":"27","author":"Syed","year":"2013","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.jddst.2021.102672_bib8","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1248\/cpb.36.1095","article-title":"A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic\/glycolic) acid","volume":"36","author":"Ogawa","year":"1988","journal-title":"Chem. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.jddst.2021.102672_bib9","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"6","key":"10.1016\/j.jddst.2021.102672_bib10","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1194\/jlr.R700005-JLR200","article-title":"Thematic review series: adipocyte Biology. Adipose tissue function and plasticity orchestrate nutritional adaptation","volume":"48","author":"Sethi","year":"2007","journal-title":"JLR (J. Lipid Res.)"},{"key":"10.1016\/j.jddst.2021.102672_bib11","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5114\/aoms.2013.33181","article-title":"Biochemistry of adipose tissue: an endocrine organ","volume":"2","author":"Coelho","year":"2013","journal-title":"Arch. Med. Sci."},{"issue":"9","key":"10.1016\/j.jddst.2021.102672_bib12","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nrd.2016.75","article-title":"Targeting adipose tissue in the treatment of obesity-associated diabetes","volume":"15","author":"Kusminski","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jddst.2021.102672_bib13","article-title":"Rosiglitazone for type 2 diabetes mellitus","volume":"3","author":"Richter","year":"2007","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.jddst.2021.102672_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/diacare.25.2.376","article-title":"Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients","volume":"25","author":"Yang","year":"2002","journal-title":"Diabetes Care"},{"issue":"24","key":"10.1016\/j.jddst.2021.102672_bib15","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.jddst.2021.102672_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/toxsci\/kfu015","article-title":"Rosiglitazone causes cardiotoxicity via peroxisome proliferator-activated receptor \u03b3-independent mitochondrial oxidative stress in mouse hearts","volume":"138","author":"He","year":"2014","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.jddst.2021.102672_bib17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jddst.2021.102672_bib18","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.addr.2012.09.004","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"64","author":"Anderson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"50","key":"10.1016\/j.jddst.2021.102672_bib19","doi-asserted-by":"crossref","first-page":"43363","DOI":"10.1021\/acsami.8b13421","article-title":"Resveratrol delivery from porous poly(lactide-co-glycolide) scaffolds promotes an anti-inflammatory environment within visceral adipose tissue","volume":"10","author":"Murphy","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jddst.2021.102672_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119281","article-title":"The host response to poly(lactide-co-glycolide) scaffolds protects mice from diet induced obesity and glucose intolerance","volume":"217","author":"Hendley","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jddst.2021.102672_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118469","article-title":"Development of microparticles for controlled release of resveratrol to adipose tissue and the impact of drug loading on particle morphology and drug release","volume":"568","author":"Isely","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.jddst.2021.102672_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ab.2012.03.005","article-title":"Protocol for effective differentiation of 3T3-L1 cells to adipocytes","volume":"425","author":"Zebisch","year":"2012","journal-title":"Anal. Biochem."},{"issue":"7","key":"10.1016\/j.jddst.2021.102672_bib23","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1023\/A:1024466407849","article-title":"PLG microsphere size controls drug release rate through several competing factors","volume":"20","author":"Berkland","year":"2003","journal-title":"Pharmaceut. Res."},{"issue":"2","key":"10.1016\/j.jddst.2021.102672_bib24","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/acs.molpharmaceut.6b00896","article-title":"Effect of particle size on drug loading and release kinetics of gefitinib-loaded PLGA microspheres","volume":"14","author":"Chen","year":"2017","journal-title":"Mol. Pharm."},{"issue":"5","key":"10.1016\/j.jddst.2021.102672_bib25","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s10856-008-3666-0","article-title":"Size effect of PLGA spheres on drug loading efficiency and release profiles","volume":"20","author":"Dawes","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"issue":"4","key":"10.1016\/j.jddst.2021.102672_bib26","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0142-9612(81)90059-4","article-title":"Present and future applications of biomaterials in controlled drug delivery systems","volume":"2","author":"Langer","year":"1981","journal-title":"Biomaterials"},{"key":"10.1016\/j.jddst.2021.102672_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2019.05.003","article-title":"Injectable, long-acting PLGA formulations: analyzing PLGA and understanding microparticle formation","volume":"304","author":"Park","year":"2019","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.jddst.2021.102672_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1289\/ehp.1308030","article-title":"Human health effects of dichloromethane: key findings and scientific issues","volume":"123","author":"Schlosser","year":"2015","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.jddst.2021.102672_bib29","doi-asserted-by":"crossref","unstructured":"H. Katou, A. J. Wandrey, and B. Gander, \"Kinetics of solvent extraction\/evaporation process for PLGA microparticle fabrication,\" Int. J. Pharm., vol. 364, no. 1, pp. 45-53, Nov 19 2008, doi: 10.1016\/j.ijpharm.2008.08.015.","DOI":"10.1016\/j.ijpharm.2008.08.015"},{"issue":"3","key":"10.1016\/j.jddst.2021.102672_bib30","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(97)01647-7","article-title":"Microencapsulation techniques using ethyl acetate as a dispersed solvent: effects of its extraction rate on the characteristics of PLGA microspheres","volume":"47","author":"Sah","year":"1997","journal-title":"J. Contr. Release"},{"issue":"20","key":"10.1016\/j.jddst.2021.102672_bib31","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1073\/pnas.1603840113","article-title":"Preventing diet-induced obesity in mice by adipose tissue transformation and angiogenesis using targeted nanoparticles","volume":"113","author":"Xue","year":"2016","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"3","key":"10.1016\/j.jddst.2021.102672_bib32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jconrel.2013.06.012","article-title":"Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity","volume":"170","author":"Di Mascolo","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jddst.2021.102672_bib33","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jconrel.2018.04.049","article-title":"Repurposing rosiglitazone, a PPAR-\u03b3 agonist and oral antidiabetic, as an inhaled formulation, for the treatment of PAH","volume":"280","author":"Rashid","year":"2018","journal-title":"J. Contr. Release"},{"issue":"7","key":"10.1016\/j.jddst.2021.102672_bib34","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1111\/add.14180","article-title":"Extended-release injectable naltrexone for opioid use disorder: a systematic review","volume":"113","author":"Jarvis","year":"2018","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.jddst.2021.102672_bib35","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.jddst.2021.102672_bib36","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/ijms18061321","article-title":"Adiponectin, a therapeutic target for obesity, diabetes, and endothelial dysfunction","volume":"18","author":"Achari","year":"2017","journal-title":"Int. J. Mol. Sci."}],"container-title":["Journal of Drug Delivery Science and Technology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S177322472100352X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S177322472100352X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:31:05Z","timestamp":1761712265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S177322472100352X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":36,"alternative-id":["S177322472100352X"],"URL":"https:\/\/doi.org\/10.1016\/j.jddst.2021.102672","relation":{},"ISSN":["1773-2247"],"issn-type":[{"value":"1773-2247","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of fabrication parameters on morphology and drug loading of polymer particles for rosiglitazone delivery","name":"articletitle","label":"Article Title"},{"value":"Journal of Drug Delivery Science and Technology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jddst.2021.102672","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102672"}}